It’s not easy to make public health decisions without access to good data. And epidemiologists and public health workers for Native American communities say they’re often in the dark because state and federal agencies restrict their access to the latest numbers.
Abbott’s neurostimulator recall, with 73 injuries reported, deemed Class I by FDA
Dive Brief: Abbott’s recall of its Proclaim and Infinity neurostimulation systems was categorized by the Food and Drug Administration as a Class I recall. Abbott contacted
September 14, 2023